Monitor this situation.
Unsubscribe anytime.
[SITUATION] · [QUIET] · [BUSINESS]
2 clusters · 5 sources · 10 days · First seen · Last updated
Nigeria NAFDAC regulatory bill opposition
Overview
Business groups and analysts have raised concerns regarding the proposed Food, Medical Products and Related Products (Registration, Etc.) Bill, 2026, also known as Senate Bill 952. The legislation seeks to repeal the Food, Drugs and Related Products Act, 2004, to establish a new regulatory framework.
The Nigeria Employers’ Consultative Association (NECA), the Standards Organisation of Nigeria (SON), and the Health Ministry have warned that the bill could create institutional conflicts and overlapping responsibilities among NAFDAC, the Federal Ministry of Health and Social Welfare, SON, and the Nigeria Customs Service. Critics argue the bill may lead to duplicative product registration, conflicting enforcement, and increased compliance costs.
A specific point of contention involves tobacco products. NECA and regulatory analyst Joel Alalade have urged that tobacco be excluded from the new legislation, noting that these products are already governed by the National Tobacco Control Act, 2015, and the National Tobacco Control Regulations, 2019. Analysts warn that introducing additional layers of authority without clearly defined boundaries could undermine the ease of doing business and weaken overall regulatory effectiveness.
Entities
Nigeria · National Agency for Food and Drug Administration and Control · Nigeria Employers’ Consultative Association · Standards Organisation of Nigeria · Joel Alalade
Timeline
-
[BUSINESS] 4 sourcesNigeria: Analyst warns NAFDAC amendment bill may cause regulatory confusion
Analyst Joel Alalade warns that the proposed NAFDAC amendment bill (SB 952) could create regulatory overlaps and increase business compliance costs in Nigeria.
-
[BUSINESS] 5 sourcesNigeria business groups oppose proposed NAFDAC regulatory bill
Nigerian business groups and the Health Ministry oppose the proposed 2026 NAFDAC Bill, warning that including tobacco products will cause regulatory duplication and increased costs for businesses.
Sources
businessday.ng · citypeopleonline.com · nationaldailyng.com · newsnowonline.com.ng · topcelebrities.com.ng